Updated:
MEDTEQ+
MEDTEQ is a nonprofit consortium founded in 2013 in Montreal, Canada. It focuses on accelerating medical technology innovation through industrial research.
MEDTEQ+
MEDTEQ is a nonprofit consortium founded in 2013 in Montreal, Canada. It focuses on accelerating medical technology innovation through industrial research. MEDTEQ offers programs to reduce risks associated with product development and commercialization.
General information
Firm type
Asset Manager
Year founded
2012
Location
Region
North America
Country
Canada
City
Montreal
Corporate office
Montreal, Quebec, Canada
Additional offices
Halifax, Nova Scotia, Canada
Principals
Alain Beaudoin
President and CEO
Sector focus
Frequently asked questions
Who runs investment decisions at MEDTEQ+?
Investment and partnership decisions are led by President and CEO Alain Beaudoin, who has headed the organization since its 2012 launch. The firm operates through a structured committee process that includes representatives from its government and private-sector funding partners, reflecting its public-private governance model.
How does MEDTEQ+ source proprietary deal flow?
MEDTEQ+ sources opportunities through its network of university-affiliated research hospitals, provincial health authorities, and industry partners who co-sponsor clinical validation projects. This embedded relationship with the healthcare delivery system gives the firm early visibility into technologies emerging from Canadian academic medical centers.
Does MEDTEQ+ participate in fund commitments or only direct deals?
MEDTEQ+ executes direct investments in health-tech companies through a combination of equity positions, repayable contributions, and non-repayable R&D co-financing. The firm does not operate as a fund-of-funds; its capital is deployed directly into operating companies alongside clinical validation support.
What investment stages does MEDTEQ+ typically target?
The firm focuses on pre-seed through Series A stages, emphasizing the translational gap between academic research and commercial viability. Its model is built around de-risking technologies through clinical validation before they require larger institutional venture rounds.
Which sectors does MEDTEQ+ explicitly avoid?
MEDTEQ+ is exclusively focused on health technology, medical devices, and digital health; it does not invest in biotech or pharmaceutical drug development, pure health-services companies without a technology component, or sectors outside healthcare.
How is MEDTEQ+ funded, and where does the underlying capital come from?
MEDTEQ+ is funded through a consortium model combining federal government programs including the Strategic Innovation Fund, provincial economic development agencies, and more than 100 private-sector industrial partners such as hospital networks and pharmaceutical firms, per the firm's official communications. It does not represent a single family's wealth.
Does MEDTEQ+ maintain a presence outside Quebec?
Yes, MEDTEQ+ operates dual hubs in Montreal, Quebec, and Halifax, Nova Scotia, reflecting a deliberate mandate to serve both central-Canadian and Atlantic Canadian health-technology clusters. Its investments span Ontario, Quebec, and the Atlantic provinces.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: